262 related articles for article (PubMed ID: 10768993)
21. Adjuvant effects of bacillus Calmette-Guerin DNA or CpG-oligonucleotide in the immune response to Taenia solium cysticercosis vaccine in porcine.
Guo YJ; Wu D; Wang KY; Sun SH
Scand J Immunol; 2007 Dec; 66(6):619-27. PubMed ID: 18021362
[TBL] [Abstract][Full Text] [Related]
22. Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route.
Jeevan A; Bonilla DL; McMurray DN
Immunology; 2009 Sep; 128(1 Suppl):e296-305. PubMed ID: 19016908
[TBL] [Abstract][Full Text] [Related]
23. The impact of alcohol on BCG-induced immunity against Mycobacterium tuberculosis.
Porretta E; Happel KI; Teng XS; Ramsay A; Mason CM
Alcohol Clin Exp Res; 2012 Feb; 36(2):310-7. PubMed ID: 22014229
[TBL] [Abstract][Full Text] [Related]
24. CHO expressed recombinant human lactoferrin as an adjuvant for BCG.
Hwang SA; Kruzel ML; Actor JK
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):452-68. PubMed ID: 26315722
[TBL] [Abstract][Full Text] [Related]
25. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
26. M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.
Hedhli D; Denis O; Barkan D; Daffé M; Glickman MS; Huygen K
PLoS One; 2013; 8(10):e76442. PubMed ID: 24146869
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by
Zatarain-Barrón ZL; Ramos-Espinosa O; Marquina-Castillo B; Barrios-Payán J; Cornejo-Granados F; Maya-Lucas O; López-Leal G; Molina-Romero C; Anthony RM; Ochoa-Leyva A; De La Rosa-Velázquez IA; Rebollar-Vega RG; Warren RM; Mata-Espinosa DA; Hernández-Pando R; van Soolingen D
Front Immunol; 2020; 11():930. PubMed ID: 32508826
[TBL] [Abstract][Full Text] [Related]
28. Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination.
Kang H; Yuan Q; Ma H; Hu ZD; Han DP; Wu K; Lowrie DB; Fan XY
Immunology; 2014 Dec; 143(4):661-9. PubMed ID: 24965530
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
30. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
31. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis.
Juffermans NP; Leemans JC; Florquin S; Verbon A; Kolk AH; Speelman P; van Deventer SJ; van der Poll T
Infect Immun; 2002 Jan; 70(1):147-52. PubMed ID: 11748176
[TBL] [Abstract][Full Text] [Related]
32. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
33. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
[TBL] [Abstract][Full Text] [Related]
34. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12.
Kranzer K; Bauer M; Lipford GB; Heeg K; Wagner H; Lang R
Immunology; 2000 Feb; 99(2):170-8. PubMed ID: 10692033
[TBL] [Abstract][Full Text] [Related]
35. The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice.
Rao M; Vogelzang A; Kaiser P; Schuerer S; Kaufmann SH; Gengenbacher M
PLoS One; 2013; 8(11):e78966. PubMed ID: 24236077
[TBL] [Abstract][Full Text] [Related]
36. Gammadelta T cells in immunity induced by Mycobacterium bovis bacillus Calmette-Guérin vaccination.
Lee J; Choi K; Olin MR; Cho SN; Molitor TW
Infect Immun; 2004 Mar; 72(3):1504-11. PubMed ID: 14977956
[TBL] [Abstract][Full Text] [Related]
37. Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.
Shang S; Shanley CA; Caraway ML; Orme EA; Henao-Tamayo M; Hascall-Dove L; Ackart D; Orme IM; Ordway DJ; Basaraba RJ
Vaccine; 2012 Feb; 30(9):1572-82. PubMed ID: 22244979
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus Calmette-Guérin vaccination.
Umemura M; Nishimura H; Saito K; Yajima T; Matsuzaki G; Mizuno S; Sugawara I; Yoshikai Y
Infect Immun; 2003 Oct; 71(10):6045-8. PubMed ID: 14500526
[TBL] [Abstract][Full Text] [Related]
39. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
Tewary P; Pandya J; Mehta J; Sukumaran B; Madhubala R
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):241-8. PubMed ID: 15364110
[TBL] [Abstract][Full Text] [Related]
40. Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain.
Aguilar D; Infante E; Martin C; Gormley E; Gicquel B; Hernandez Pando R
Clin Exp Immunol; 2007 Feb; 147(2):330-8. PubMed ID: 17223975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
